Literature DB >> 11313035

Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis.

W R Kates1, C P Burnette, E W Jabs, J Rutberg, A M Murphy, M Grados, M Geraghty, W E Kaufmann, G D Pearlson.   

Abstract

BACKGROUND: Velocardiofacial syndrome, caused by a microdeletion on chromosome 22q.11, is associated with craniofacial anomalies, cardiac defects, learning disabilities, and psychiatric disorders. To understand how the 22q.11 deletion affects brain development, this study examined gray and white matter volumes in major lobar brain regions of children with velocardiofacial syndrome relative to control subjects.
METHODS: Subjects were ten children with velocardiofacial syndrome and ten age- and gender-matched unaffected children. Coronal images were acquired with a 3-D spoiled gradient echo series and partitioned into 124, 1.5-mm contiguous slices. A stereotaxic grid was used to subdivide brain tissue into cerebral lobes, which were segmented into gray, white, and CSF compartments using an algorithm based on intensity values and tissue boundaries. Nonparametric statistics were used to compare lobar volumes of gray and white matter.
RESULTS: Analyses indicated that children with velocardiofacial syndrome had significantly smaller volumes in nonfrontal, but not frontal, lobar brain regions. Volume reductions affected nonfrontal white matter to a greater extent than nonfrontal gray matter.
CONCLUSIONS: The presence of white matter reductions may be related to disturbances in myelination or axonal integrity in velocardiofacial syndrome. Further work is required to delineate the nature and extent of white matter anomalies, and to link them to variation in the neurocognitive and neuropsychiatric phenotype of velocardiofacial syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11313035     DOI: 10.1016/s0006-3223(00)01002-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  68 in total

Review 1.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

2.  Chromosome 22q11.2 deletion syndrome: an underestimated cause of neuropsychiatric impairment in adolescence.

Authors:  Dimitrios Parissis; Ioannis Milonas
Journal:  J Neurol       Date:  2005-07-27       Impact factor: 4.849

3.  Domain specific attentional impairments in children with chromosome 22q11.2 deletion syndrome.

Authors:  Joel P Bish; Renee Chiodo; Victoria Mattei; Tony J Simon
Journal:  Brain Cogn       Date:  2007-05-11       Impact factor: 2.310

Review 4.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 5.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

Review 6.  A new account of the neurocognitive foundations of impairments in space, time and number processing in children with chromosome 22q11.2 deletion syndrome.

Authors:  Tony J Simon
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Structure-specific statistical mapping of white matter tracts.

Authors:  Paul A Yushkevich; Hui Zhang; Tony J Simon; James C Gee
Journal:  Neuroimage       Date:  2008-01-26       Impact factor: 6.556

8.  Visuospatial and numerical cognitive deficits in children with chromosome 22q11.2 deletion syndrome.

Authors:  Tony J Simon; Carrie E Bearden; Donna McDonald Mc-Ginn; Elaine Zackai
Journal:  Cortex       Date:  2005-04       Impact factor: 4.027

Review 9.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

10.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.